SANUWAVE Health, Inc.: Director Jeffrey Blizard received 11,286 shares

What happened Jeffrey Blizard, director, received a grant of 11,286 derivative securities (acquisition code A) at an acquisition price of $0.00, total value $0, on Sep 30, 2026. The filing notes these were options that were fully vested at the grant date.

Key details

• Transaction date and price: Sep 30, 2026 at $0.00 (code A: grant/award)
• Shares owned after the transaction: not stated in the filing
• Footnote: F1 — options were fully vested at the grant date
• Filing date: Oct 2, 2026; late filing: not indicated in the filing

Why it may matter

• This filing reports a grant of derivative securities (options) that were fully vested at the grant date.
• A filing does not show why the insider traded or why the company acted.